Genomic infrastructure for UAE healthcare
Genomics-backed EHR to Insurance translational layer.
- Genomics and clinical intelligence on the system you already run.
- Intelligence from patient data directly in your workflow.
- Zero rip-and-replace. No new systems or software to use.
Production: edge-deployed on-premise · POC & pilot: Microsoft Azure UAE North
What is AGenomics API?
The missing layer between genomic medicine and insurance reality.
AGenomics API is an edge-deployed intelligence layer that reads a patient's genomic and clinical data once, producing two outcomes from a single pass.
When a clinician opens a chart or writes a prescription, it delivers real-time pharmacogenomic (PGx), drug–drug interaction and ADR alerts inside the hospital's existing system — through HL7 CDS Hooks, supported by Epic, Oracle Health and modern UAE hospital systems. From that same evidence, it generates a scored, evidence-attached insurance claim, ready for submission through the UAE's existing clearinghouse infrastructure.
Clinical safety platforms solve the first problem. Prior-authorisation and claim automation tools solve the second. AGenomics recognised they were never two problems — the same data, seen from two rooms in the same hospital.
Patient journey flow map
Same data. Safer patient. Cleaner claim.
Nothing prescribed blind.
Every order checked against the patient's own genotype and active medications before it's written — not flagged after dispensing.
Nothing indicated goes unordered.
Guideline-required companion diagnostics surface while the patient is still in the chair, with the guideline that indicates them attached.
Nothing submitted unevidenced.
Claims leave with clinical justification and the patient's payer rules already applied — fewer denials, less rework, revenue that was always earned.
The idea, in one line
Stripe abstracted payments.
AGenomics abstracts genomic medicine.
Stripe saw every company rebuilding the same regulated payments plumbing. It made that plumbing a few API calls — years of integration became days.
AGenomics applies the pattern to genomic medicine. Variant interpretation, pharmacogenomic reasoning and payer-ready claim scoring sit behind standards your hospital already speaks: HL7 v2, FHIR R4, CDS Hooks. One endpoint, not a new system. Like Stripe, it's invisible when it works: physicians see a better alert, billers a cleaner claim.
POST https://edge.hospital.ae/agenomics/cds-services
# hook: medication-prescribe → graded PGx alert
# same pass → scored, evidence-attached claimWhat · Whom · Why · How
Four questions, answered before you ask them.
The layer between genomic medicine and insurance reality.
A single edge-deployed engine that reads genomic + clinical data once and returns both a real-time safety alert and a payer-ready, evidence-scored claim.
Hospitals that already own the data but can't yet act on it.
Built for hospital owners, CEOs, CMOs, CIOs, CFOs, RCM and billing leaders — and for the M42 ecosystem shaping UAE health infrastructure.
The insight already exists. It just never arrives in time.
Genomic reports sit two systems away from the prescription and the claim. AGenomics closes that distance at the exact moment it matters — the point of care and the point of billing.
No rip-and-replace. One endpoint, standards you already run.
Connects via HL7 v2.x, FHIR R4, and CDS Hooks; will read from Malaffi and Nabidh; processes genomic data with residency inside the UAE. Your HIS, clearinghouse, and payer contracts stay exactly as they are.
Why AGenomics API for the UAE · Why now
Three national investments. One missing connection.
The UAE has built three things most health systems lack even one of: a national genome programme generating pharmacogenomic data at scale; health information exchanges — Malaffi, Nabidh, Riayati — making clinical data queryable across facilities; and FHIR R4-based claims infrastructure through DOH and DHA.
What's missing is the layer connecting all three to the point of care and the point of billing at once. Not a technology gap — the infrastructure exists. A connection gap.
With insurers tightening scrutiny on genomic claims and Saudi's Nphies opening a GCC-wide path, the window to build this connective layer first is open now — aligned with the UAE's HealthTech vision and ambitions.
800K+
Genomes sequenced, as of Feb 2026
160K+
PGx reports, as of Apr 2025
3
National HIEs — Malaffi · Nabidh · Riayati
FHIR R4
Native, end to end
Prove it on your own hospital data. Commit to nothing.
A scoped, 90-day pilot on a single service line. No system replaced, no hospital-wide licence, no obligation to continue. You see denial-rate movement and prescribing risks surfaced on your own numbers — then decide.
PDPL-compliant by architecture — read how